These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 26112648

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
    Ho YJ, Liu FC, Yeh CT, Yang CM, Lin CC, Lin TY, Hsieh PS, Hu MK, Gong Z, Lu JW.
    Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
    [Abstract] [Full Text] [Related]

  • 5. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L, Segura Guerrero N, Tas A, Quérat G, Pastorino B, Froeyen M, Dallmeier K, Jochmans D, Herdewijn P, Bello F, Snijder EJ, de Lamballerie X, Martina B, Neyts J, van Hemert MJ, Leyssen P.
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [Abstract] [Full Text] [Related]

  • 6. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC, White-Scholten L, Tas A, Hoornweg TE, Ferla S, Kovacikova K, Smit JM, Brancale A, Snijder EJ, van Hemert MJ.
    Viruses; 2020 Mar 17; 12(3):. PubMed ID: 32191995
    [Abstract] [Full Text] [Related]

  • 7. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ, Wang YM, Lu JW, Wu TY, Lin LI, Kuo SC, Lin CC.
    PLoS One; 2015 Mar 17; 10(7):e0133511. PubMed ID: 26208101
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.
    mBio; 2016 May 24; 7(3):. PubMed ID: 27222471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of andrographolide against chikungunya virus infection.
    Wintachai P, Kaur P, Lee RC, Ramphan S, Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ, Smith DR.
    Sci Rep; 2015 Sep 18; 5():14179. PubMed ID: 26384169
    [Abstract] [Full Text] [Related]

  • 12. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
    Weber C, Sliva K, von Rhein C, Kümmerer BM, Schnierle BS.
    Antiviral Res; 2015 Jan 18; 113():1-3. PubMed ID: 25446334
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
    Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P.
    PLoS One; 2011 Jan 18; 6(12):e28923. PubMed ID: 22205980
    [Abstract] [Full Text] [Related]

  • 14. Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead.
    Nothias-Scaglia LF, Retailleau P, Paolini J, Pannecouque C, Neyts J, Dumontet V, Roussi F, Leyssen P, Costa J, Litaudon M.
    J Nat Prod; 2014 Jun 27; 77(6):1505-12. PubMed ID: 24926807
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Inhibition of Alphaviruses by Lycorine.
    Li N, Wang Z, Wang R, Zhang ZR, Zhang YN, Deng CL, Zhang B, Shang LQ, Ye HQ.
    Virol Sin; 2021 Dec 27; 36(6):1465-1474. PubMed ID: 34374926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Suramin treatment reduces chikungunya pathogenesis in mice.
    Kuo SC, Wang YM, Ho YJ, Chang TY, Lai ZZ, Tsui PY, Wu TY, Lin CC.
    Antiviral Res; 2016 Oct 27; 134():89-96. PubMed ID: 27577529
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P, Thiruchelvan M, Lee RC, Chen H, Chen KC, Ng ML, Chu JJ.
    Antimicrob Agents Chemother; 2013 Jan 27; 57(1):155-67. PubMed ID: 23275491
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.
    Abdelnabi R, Staveness D, Near KE, Wender PA, Delang L, Neyts J, Leyssen P.
    Biochem Pharmacol; 2016 Nov 15; 120():15-21. PubMed ID: 27664855
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus.
    Lu JW, Hsieh PS, Lin CC, Hu MK, Huang SM, Wang YM, Liang CY, Gong Z, Ho YJ.
    Biochem Biophys Res Commun; 2017 Sep 23; 491(3):595-602. PubMed ID: 28760340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.